Number of Shares
2.06 Mil
Current Holdings Value*
$38.08 Mil
% of Portfolio
7.37%
Total Estimate Gain
$4.14 Mil
% of Total Estimate Gain
9.09%

Octagon Capital Advisors LP's ArriVent BioPharma Inc Holding Summary

As of 2025-03-31, Octagon Capital Advisors LP held 2.06 Mil shares of ArriVent BioPharma Inc(AVBP), totaling $38.08 Mil. This investment constitutes 7.37% of their stock portfolio, and Octagon Capital Advisors LP now holds 6.02% of the outstanding ArriVent BioPharma Inc(AVBP) stock.

The initial trade took place in 2024Q1. And since then Octagon Capital Advisors LP has made 3 purchases of AVBP, at an average price of $20.69, for a total of 2.20 Mil shares. In addition, there have been 1 sales at an average price of $17.83 for 140,532.00 shares. Based on historical transaction data and AVBP's current price of $22.90, Octagon Capital Advisors LP's estimated gain on his AVBP holdings is $4.14 Mil, reflecting a 9.09% gain to date.

Octagon Capital Advisors LP AVBP ($22.90) Holding Chart

Octagon Capital Advisors LP AVBP ($22.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1